Takatsugu Murata - Search Results

Year	Number of Results
2017	2
2018	3
2019	2
2021	2

1

Total Synthesis of Violaceoid A and (-)- and (+)-Violaceoid B.

Murata T, Kuboki T, Ishikawa R, Saito T, Taguchi S, Takeuchi K, Hatano E, Shimonaka M, Shiina I. Murata T, et al. J Nat Prod. 2018 Nov 26;81(11):2364-2370. doi: 10.1021/acs.jnatprod.8b00215. Epub 2018 Oct 30. J Nat Prod. 2018. PMID: 30375869

2

Total Synthesis and Antimicrobial Evaluation of 23-Demethyleushearilide and Extensive Antimicrobial Evaluation of All Synthetic Stereoisomers of (16Z,20E)-Eushearilide and (16E,20E)-Eushearilide.

Tonoi T, Inohana T, Sato T, Noda Y, Ikeda M, Akutsu M, Murata T, Maekawa Y, Tanaka A, Seki R, Ohkusu M, Kamei K, Ishiwada N, Shiina I. Tonoi T, et al. Among authors: murata t. Molecules. 2019 Sep 22;24(19):3437. doi: 10.3390/molecules24193437. Molecules. 2019. PMID: 31546686 Free PMC article.

3

N822K- or V560G-mutated KIT activation preferentially occurs in lipid rafts of the Golgi apparatus in leukemia cells.

Obata Y, Hara Y, Shiina I, Murata T, Tasaki Y, Suzuki K, Ito K, Tsugawa S, Yamawaki K, Takahashi T, Okamoto K, Nishida T, Abe R. Obata Y, et al. Among authors: murata t. Cell Commun Signal. 2019 Sep 4;17(1):114. doi: 10.1186/s12964-019-0426-3. Cell Commun Signal. 2019. PMID: 31484543 Free PMC article.

4

Kinetic Resolution of Racemic 2-Hydroxyamides Using a Diphenylacetyl Component as an Acyl Source and a Chiral Acyl-Transfer Catalyst.

Murata T, Kawanishi T, Sekiguchi A, Ishikawa R, Ono K, Nakata K, Shiina I. Murata T, et al. Molecules. 2018 Aug 10;23(8):2003. doi: 10.3390/molecules23082003. Molecules. 2018. PMID: 30103468 Free PMC article.

5

4-(Dimethylamino)pyridine N-Oxide-Catalyzed Macrolactamization Using 2-Methyl-6-nitrobenzoic Anhydride in the Synthesis of the Depsipeptidic Analogue of FE399.

Tonoi T, Inohana T, Kawahara R, Sato T, Ikeda M, Akutsu M, Murata T, Shiina I. Tonoi T, et al. Among authors: murata t. ACS Omega. 2021 Jan 11;6(5):3571-3577. doi: 10.1021/acsomega.0c04878. eCollection 2021 Feb 9. ACS Omega. 2021. PMID: 33585740 Free PMC article.

6

M-COPA suppresses endolysosomal Kit-Akt oncogenic signalling through inhibiting the secretory pathway in neoplastic mast cells.

Hara Y, Obata Y, Horikawa K, Tasaki Y, Suzuki K, Murata T, Shiina I, Abe R. Hara Y, et al. Among authors: murata t. PLoS One. 2017 Apr 12;12(4):e0175514. doi: 10.1371/journal.pone.0175514. eCollection 2017. PLoS One. 2017. PMID: 28403213 Free PMC article.

7

FLT3-ITD transduces autonomous growth signals during its biosynthetic trafficking in acute myelogenous leukemia cells.

Yamawaki K, Shiina I, Murata T, Tateyama S, Maekawa Y, Niwa M, Shimonaka M, Okamoto K, Suzuki T, Nishida T, Abe R, Obata Y. Yamawaki K, et al. Among authors: murata t. Sci Rep. 2021 Nov 22;11(1):22678. doi: 10.1038/s41598-021-02221-2. Sci Rep. 2021. PMID: 34811450 Free PMC article.

8

Oncogenic Kit signalling on the Golgi is suppressed by blocking secretory trafficking with M-COPA in gastrointestinal stromal tumours.

Obata Y, Horikawa K, Shiina I, Takahashi T, Murata T, Tasaki Y, Suzuki K, Yonekura K, Esumi H, Nishida T, Abe R. Obata Y, et al. Among authors: murata t. Cancer Lett. 2018 Feb 28;415:1-10. doi: 10.1016/j.canlet.2017.11.032. Epub 2017 Nov 28. Cancer Lett. 2018. PMID: 29196126 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results